• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Alveolar Soft Part Sarcoma

Alveolar Soft Part Sarcoma - 24 Studies Found

Active, not recruiting : Vaccine Trial for Clear Cell Sarcoma, Pediatric Renal Cell Carcinoma, Alveolar Soft Part Sarcoma and Children With Stage IV Melanoma
:
  • Sarcoma, Clear Cell
  • Sarcoma, Alveolar Soft Part
  • Renal Cell
    : 2005-11-23
    : Biological: GVAX 4 vaccines every two weeks
Not yet recruiting : Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
:
  • Adult Alveolar Soft-part Sarcoma
  • Adult Angiosarcoma
  • : 2006-06-28
    :
    • Drug: doxorubicin hydrochloride

Completed : CREATE: Cross-tumoral Phase 2 With Crizotinib
:
  • Locally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma
  • Locally Advanced and/or Me
    : 2012-01-24
    : Drug: Crizotinib (PF-02341066) For patients of 15yo and older, Capsules of 200 and 250 mg Daily dose of
Recruiting : Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-Rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery
:
  • Adult Fibrosarcoma
  • Alveolar Soft Part Sarcoma
  • Drug: Doxorubicin Hydrochloride

Completed : Gemcitabine Hydrochloride With or Without Pazopanib Hydrochloride in Treating Patients With Refractory Soft Tissue Sarcoma
:
  • Adult Alveolar Soft Part Sarcoma
  • Adult Angiosarcoma
  • : 2012-02-06
    :
    • Drug: Gemcitabine Hydrochloride

Completed : Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma
:
  • Adult Alveolar Soft Part Sarcoma
  • Adult Angiosarcoma
  • : 2010-06-29
    :
    • Drug: Gamma-Secretase Inhibitor RO4929097

Completed : Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma
:
  • Adult Alveolar Soft-part Sarcoma
  • Adult Angiosarcoma
  • : 2005-06-02
    : Drug: romidepsin DEP is administered at a dose of 13 mg/m2 as a 4-hour intravenous infusion in the outpa
Active, not recruiting : Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma
:
  • Childhood Alveolar Soft-part Sarcoma
  • Childhood Angiosarcoma : 2012-06-06
    :
    • Biological: cixutumumab Given

Completed : Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue Sarcomas
:
  • Childhood Alveolar Soft-part Sarcoma
  • Childhood Angiosarcoma : 2012-03-27
    : Other: laboratory biomarker analysis Correlative studies
Completed : Surgery With or Without Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Retroperitoneum or Pelvis
: Sarcoma
: 2004-09-07
:
  • Procedure: conventional surgery
  • Radiation:

<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.